Cullinan Therapeutics, Inc. (CGEM)
14.70
-0.28
(-1.90%)
USD |
NASDAQ |
May 07, 16:00
14.70
0.00 (0.00%)
After-Hours: 20:00
Cullinan Therapeutics EPS Diluted (Quarterly) : -0.8566 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.742 |
| Elevance Health, Inc. | 8.004 |
| Nkarta, Inc. | -0.3702 |
| Janux Therapeutics, Inc. | -0.514 |
| Zenas BioPharma, Inc. | -5.172 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.71M |
| Total Expenses (Quarterly) | 50.71M |
| Enterprise Value | 532.07M |
| Earnings Yield | -25.32% |
| Normalized Earnings Yield | -25.32 |